D
Nanobiotix S.A. NBTX
$21.00 $0.512.49% NASDAQ
Recommendation
Prev Close
$20.49
Volume
19,131
Avg Vol (90D)
73,673
Market Cap
$984.26M
Dividend & Yield
--
52-Week Range
$2.76 - $30.35
P/E (TTM)
--
EPS (TTM)
-$1.18
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Nanobiotix (NASDAQ:NBTX) Shares Gap Down - Here's Why
11/27/2025 - MarketBeat
FY2026 EPS Estimates for Nanobiotix Decreased by Analyst
11/27/2025 - MarketBeat
Nanobiotix SA (NBTX, $20.38) entered Downtrend as Momentum indicator drops below 0 level on Nov 26, 2025
11/27/2025 - Tickeron - Technical Analysis
Nanobiotix SA (NBTX, $20.38) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 26, 2025
11/27/2025 - Tickeron - Technical Analysis
Nanobiotix SA (NBTX, $20.38) price exceeded its 50-day Moving Average on November 26, 2025
11/27/2025 - Tickeron - Technical Analysis
Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX) Receives Consensus Recommendation of "Hold" from Brokerages
11/26/2025 - MarketBeat
Nanobiotix SA (NBTX, $22) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 24, 2025
11/25/2025 - Tickeron - Stocks
Nanobiotix SA (NBTX, $22) entered Downtrend as Momentum indicator drops below 0 level on Nov 24, 2025
11/25/2025 - Tickeron - Stocks
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 ...
11/24/2025 - GuruFocus
Nanobiotix Secures $71 Million Financing and Advances Cancer Treatment Programs
11/24/2025 - TipRanks Financial Blog
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
11/24/2025 - Globe Newswire
Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue
11/24/2025 - Yahoo! Finance: News
Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue
11/24/2025 - Fool.com Headlines
Nanobiotix SA (NBTX, $20.93) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 21, 2025
11/22/2025 - Tickeron - Stocks
Nanobiotix (NASDAQ:NBTX) Shares Gap Up - Here's What Happened
11/19/2025 - Ticker Report
Nanobiotix SA (NBTX, $21.89) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 17, 2025
11/18/2025 - Tickeron - Stocks
Nanobiotix (NASDAQ:NBTX) Shares Gap Up - Should You Buy?
11/18/2025 - MarketBeat
Nanobiotix Advances Curadigm Nanoprimer Platform with New Patents and Preclinical Data
11/14/2025 - TipRanks Financial Blog
Voting Rights and Shares Capital of the Company
11/14/2025 - Globe Newswire
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal ...
11/13/2025 - GuruFocus
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
11/13/2025 - Globe Newswire
Nanobiotix (NASDAQ:NBTX) Shares Gap Down - Time to Sell?
11/12/2025 - MarketBeat
NANOBIOTIX to Participate in Jefferies London Healthcare Conference
11/11/2025 - GuruFocus
NANOBIOTIX to Participate in Jefferies London Healthcare Conference
11/11/2025 - Globe Newswire
Nanobiotix (NASDAQ:NBTX) Shares Gap Up - Should You Buy?
11/11/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$11.29M
EBITDA (TTM)
-$46.90M
EBIT (TTM)
-$47.53M
Net Income (TTM)
-$55.97M
Balance Sheet
Total Assets (Q)
$53.05M
Total Debt (Q)
$60.18M
Total Liabilities (Q)
$134.03M
Book Value Per Share (Q)
-$1.68
Cash Flow
Cash from Operations (TTM)
-$33.89M
Cash from Investing (TTM)
-$669.70K
Cash from Financing (TTM)
-$5.78M
Net Change in Cash (TTM)
-$40.85M
Filings
Filing Date
Tuesday, September 30, 2025
Period Date
Monday, June 30, 2025
Next Filing
Beginning of April (est)
Price History
Loading...
Beta
0.78
7-Day Total Return
0.33%
30-Day Total Return
-7.16%
60-Day Total Return
129.71%
90-Day Total Return
216.02%
Year to Date Total Return
624.14%
1-Year Total Return
624.14%
2-Year Total Return
252.64%
3-Year Total Return
449.02%
5-Year Total Return
23.67%
52-week Low
Dec 05, 2024 - $2.76
52-week High
Oct 13, 2025 - $30.35
Valuation
Market Cap
$984.26M - Small Cap
Enterprise Value
$1.01B
Price/Sales (TTM)
86.06
Price/Book (Q)
-12.20
Dividends and Shares
Shares Outstanding
47.42
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.nanobiotix.com
Phone Number
33 1 40 26 04 70
Address
60 rue de Wattignies
Paris, 75012
Country
France
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is... more
NASDAQ 12/03/2025 3:07PM Eastern Quotes delayed